Richard Ivell firstname.lastname@example.org
Relaxin-like peptides in male reproduction: a human perspective
Ivell, Richard; Agoulnik, Alexander I.; Anand-Ivell, Ravinder
Alexander I. Agoulnik
RAVINDER ANAND-IVELL Ravinder.Anandemail@example.com
The relaxin family of peptide hormones and their cognate GPCRs are becoming physiologically well-characterized in the cardiovascular system and particularly in female reproductive processes. Much less is known about the physiology and pharmacology of these peptides in male reproduction, particularly as regards humans. H2-relaxin is involved in prostate function and growth, while insulin-like peptide 3 (INSL3) is a major product of the testicular Leydig cells and, in the adult, appears to modulate steroidogenesis and germ cell survival. In the fetus, INSL3 is a key hormone expressed shortly after sex determination and is responsible for the first transabdominal phase of testicular descent. Importantly, INSL3 is becoming a very useful constitutive biomarker reflecting both fetal and post-natal development. Nothing is known about roles for INSL4 in male reproduction and only very little about relaxin-3, which is mostly considered as a brain peptide, or INSL5. The former is expressed at very low levels in the testes, but has no known physiology there, whereas the INSL5 knockout mouse does exhibit a testicular phenotype with mild effects on spermatogenesis,probably due to a disruption of glucose homeostasis. INSL6 is a major product of male germ cells, although it is relatively unexplored with regard to its physiology or pharmacology, except that in mice disruption of the INSL6 gene leads to a disruption of spermatogenesis. Clinically, relaxin analogues may be useful in the control of prostate cancer, and both relaxin and INSL3 have been considered as sperm adjuvants for in vitro fertilization.
Ivell, R., Agoulnik, A. I., & Anand-Ivell, R. (2017). Relaxin-like peptides in male reproduction: a human perspective. British Journal of Pharmacology, 174(10), https://doi.org/10.1111/bph.13689
|Journal Article Type||Article|
|Acceptance Date||Dec 5, 2016|
|Online Publication Date||Feb 27, 2017|
|Publication Date||Apr 26, 2017|
|Deposit Date||Mar 22, 2017|
|Publicly Available Date||Mar 22, 2017|
|Journal||British Journal of Pharmacology|
|Peer Reviewed||Peer Reviewed|
|Keywords||GEO, gene expression omnibus; INSL3–6, insulin-like peptide 3–6; LGR7, leucine-rich repeat-containing GPCR 7, synonymous
with RXFP1; LH, luteinizing hormone; RLN2, H2-relaxin; RLN3, relaxin-3; RXFP1–4, relaxin family peptide receptor 1–4
|Copyright Statement||Copyright information regarding this work can be found at the following address: http://eprints.nottingh.../end_user_agreement.pdf|
|Additional Information||This article is part of a themed section on Recent Progress in the Understanding of Relaxin Family Peptides and their Receptors. To view the other articles in this section visit http://onlinelibrary.wi...1/bph.v174.10/issuetoc.
This is the peer reviewed version of the following article: Ivell, R., Agoulnik, A. I., and Anand-Ivell, R. (2017) Relaxin-like peptides in male reproduction – a human perspective. British Journal of Pharmacology, 174: 990–1001, which has been published in final form at http://dx.doi.org/10.1111/bph.13689. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf
You might also like
Effects of acute hCG stimulation on serum INSL3 and 25‐OH vitamin D in Klinefelter syndrome
Prepubertal nutrition alters Leydig cell functional capacity and timing of puberty
Insulin-like peptide 3 (INSL3) is a major regulator of female reproductive physiology
Testicular function and bone in young men with severe childhood-onset obesity.